Skip to main content
Equibles

John Tattory

CFO

Transcode Therapeutics, Inc. (RNAZ)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About John Tattory

John Tattory is recorded as CFO at Transcode Therapeutics, Inc. (RNAZ). Transcode Therapeutics, Inc. reported in an 8-K filed September 11, 2026 that John Tattory was appointed Interim Chief Financial Officer, effective September 9, 2026.

“John Tattory was appointed to serve as the Company’s Interim Chief Financial Officer, principal financial officer and principal accounting officer, effective as of September 9, 2026.”
Transcode Therapeutics, Inc. Form 8-K, filed September 11, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Transcode Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.